Reversible choreoathetosis as the early onset of HIV-encephalopathy.
Passarin
M G
MG
Alessandrini
F
F
Nicolini
G G
GG
Musso
A
A
Gambina
G
G
Moretto
G
G
D015526:AIDS Dementia Complex / Q000150:complications* / Q000000981:diagnostic imaging / Q000473:pathology; D017668:Age of Onset; D000998:Antiviral Agents / Q000627:therapeutic use; D001264:Athetosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology*; D001284:Atrophy / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology; D001479:Basal Ganglia / Q000000981:diagnostic imaging / Q000473:pathology* / Q000503:physiopathology; D002819:Chorea / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology*; D004569:Electroencephalography; D020233:Gait Disorders, Neurologic / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008569:Memory Disorders / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology; D008875:Middle Aged; D019964:Mood Disorders / Q000000981:diagnostic imaging / Q000473:pathology / Q000821:virology; D009413:Nerve Fibers, Myelinated / Q000473:pathology / Q000821:virology; D049268:Positron-Emission Tomography; D017397:Prefrontal Cortex / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D011480:Protease Inhibitors / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D011480:Protease Inhibitors; D012367:RNA, Viral